STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Uipath Inc SEC Filings

PATH NYSE

Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

UiPath’s automation story is written in its SEC filings. Each 10-K reveals how subscription licensing and cloud-based robots turn repetitive tasks into scalable revenue, while Form 4s track when executives buy or sell shares in a fast-moving RPA market. This page brings every disclosure together, from the smallest 8-K on product releases to the comprehensive proxy statement on executive compensation.

Stock Titan’s AI reads the dense language so you don’t have to. Need the UiPath quarterly earnings report 10-Q filing? We surface ARR, customer count, and cloud mix in plain English. Curious about UiPath insider trading Form 4 transactions? Real-time alerts flag patterns before the market notices. Our AI-powered summaries translate revenue recognition notes, goodwill impairment tests, and segment performance into straightforward takeaways, making understanding UiPath SEC documents with AI effortless.

Here’s what you can explore:

  • Annual depth: UiPath annual report 10-K simplified with key automation metrics, risk factors, and cash-flow drivers.
  • Quarterly pulse: Side-by-side 10-Q comparisons for sequential growth and margin shifts, plus UiPath earnings report filing analysis.
  • Event trackers: UiPath 8-K material events explained within minutes of EDGAR release.
  • Insider lens: UiPath Form 4 insider transactions real-time and archived UiPath executive stock transactions Form 4.
  • Governance focus: The latest UiPath proxy statement executive compensation summarized for pay-performance alignment.

Whether you’re quantifying automation adoption or monitoring governance, Stock Titan delivers comprehensive coverage, AI-powered summaries, and immediate updates—UiPath SEC filings explained simply, every time.

Filing
Rhea-AI Summary

UiPath (PATH) received an amended Schedule 13G (Amendment No. 1) from co-founder Daniel Dines reporting his beneficial ownership. As of September 30, 2025, Dines beneficially owned 105,697,391 shares, equal to 19.9% of Class A on an as-converted basis and representing 86.1% of the company’s total voting power.

The stake comprises 31,631,388 shares of Class A (held via IceVulcan Investments Ltd and Ice Vulcan Holding Limited) and 74,306,003 shares of Class B (held via Ice Vulcan Holding Limited). Class B converts 1‑for‑1 into Class A and carries 35 votes per share versus one vote for Class A. As of October 13, 2025, Dines no longer has voting or dispositive power over 240,000 Class A shares previously reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

UiPath (PATH): Insider transaction disclosed. A reporting person who serves as CEO and Chairman, and is also a director and 10% owner, sold 45,000 shares of Class A common stock on 11/05/2025. The reported transaction price was $15.0748 per share; the filing notes executions occurred between $15.00 and $15.15 under a Rule 10b5-1 trading plan. Following the sale, the reporting person directly owned 29,288,585 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
insider
-
Rhea-AI Summary

UiPath, Inc. (PATH) insider transaction: The CEO and Chairman, who is also a Director and 10% Owner, reported selling 45,000 shares of Class A Common Stock on 11/04/2025 under a Rule 10b5-1 trading plan. The reported execution price for the sale is $15.0243, with the filing noting a trade range from $15.0000 to $15.1200.

Following this transaction, the reporting person beneficially owns 29,333,585 shares, held directly. The filing indicates the trade was executed pursuant to a pre-established plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath (PATH) CEO and Chairman Daniel Dines reported an insider sale. On 11/03/2025, he sold 45,000 shares of Class A common stock at an average price of $16.2264, executed under a qualified Rule 10b5-1 trading plan. The reported trade price range was $16.0500 to $16.4200.

Following this transaction, Dines beneficially owned 29,378,585 shares, held directly. He is listed as Director, Officer, and 10% Owner. The filing notes full trade details are available upon request to the company or Commission staff.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) insider activity: CEO and Chairman (also a 10% owner) reported selling 45,000 shares of Class A common stock on 10/31/2025 at an average price of $15.7171. The transaction was executed pursuant to a qualified Rule 10b5-1 trading plan.

Following the sale, the reporting person beneficially owns 29,423,585 shares, held directly. The filing notes the sale prices ranged from $15.5700 to $15.8500, with full trade-by-trade details available upon request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) insider transaction: A reporting person who is the CEO and Chairman, Director, and a 10% Owner reported selling 45,000 shares of Class A common stock on 10/30/2025 at an average price of $15.7254 under a Rule 10b5-1 trading plan. The disclosed trade occurred within a price range of $15.4500 to $16.0000. Following the sale, the filer beneficially owns 29,468,585 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath (PATH) CEO and Chairman, who is also a Director and 10% Owner, reported open-market sales of Class A common stock under a Rule 10b5-1 trading plan. He sold 45,000 shares on 10/27/2025 at a weighted average price of $16.726, 45,000 shares on 10/28/2025 at $17.1632, and 45,000 shares on 10/29/2025 at $16.2874.

Following these transactions, the reporting person beneficially owned 29,513,585 shares of Class A common stock. A footnote states he no longer has a reportable beneficial interest in 240,000 shares previously included in ownership reports.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its CEO and Chairman, who is also a 10% owner. On 10/24/2025, he sold 45,000 shares of Class A common stock in an open market sale pursuant to a Rule 10b5-1 trading plan. The sale price averaged $15.4578, with a disclosed range from $15.3200 to $15.5600.

Following the transaction, the reporting person beneficially owns 29,648,585 shares directly and 240,000 shares indirectly through a spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its CEO and Chairman. On 10/23/2025, the reporting person sold 45,000 Class A shares at an average price of $15.1853, with a range of $15.0000–$15.3300, pursuant to a Rule 10b5-1 plan. Following the sale, beneficial ownership stood at 29,693,585 shares directly and 240,000 shares indirectly by spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.73%
Tags
insider
Rhea-AI Summary

UiPath (PATH) insider transaction: The company’s CEO and Chairman, who is also a Director and 10% owner, reported selling 45,000 shares of Class A common stock on 10/22/2025 under a Rule 10b5-1 trading plan. The reported price was $15.5312, with trades executed in a range from $15.3700 to $15.8000.

Following the sale, the reporting person beneficially owns 29,738,585 shares directly and 240,000 shares indirectly through a spouse. This filing reflects a planned disposition under a qualified selling plan and provides price-range details upon request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Uipath (PATH)?

The current stock price of Uipath (PATH) is $13.52 as of November 17, 2025.

What is the market cap of Uipath (PATH)?

The market cap of Uipath (PATH) is approximately 7.5B.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Stock Data

7.45B
415.64M
9.44%
82.2%
10.47%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK